宣泰医药 (688247.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(宣泰医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 45.0069.0046.0054.0056.0064.0076.0068.0078.00
 单季度销售净利率(%) 21.0020.0021.0022.0018.0043.0046.0031.0032.00
 单季度净资产收益率ROE(%) 2.001.002.001.001.002.003.003.003.00
 单季度总资产净利率ROA(%) 2.001.002.001.001.002.002.002.002.00
单季度财务摘要:
 单季度营业总收入(元) 111,411,602.0086,506,944.00102,598,921.0068,347,159.0042,418,265.0060,658,823.0059,050,376.0064,674,024.0063,179,210.00
 单季度营业总成本(元) 85,556,448.0071,628,844.0082,135,231.0053,144,607.0039,083,317.0057,788,545.0036,655,046.0046,510,124.0042,469,220.00
 单季度营业收入(元) 111,411,602.0086,506,944.00102,598,921.0068,347,159.0042,418,265.0060,658,823.0059,050,376.0064,674,024.0063,179,210.00
 单季度营业利润(元) 26,588,026.0021,119,730.0022,912,624.0017,155,680.007,823,730.0025,769,439.0028,136,293.0021,773,107.0023,452,801.00
 单季度利润总额(元) 26,403,629.0018,106,978.0022,829,012.0017,230,870.007,823,922.0024,988,299.0028,137,897.0021,691,943.0022,657,282.00
 单季度净利润(元) 22,895,905.0017,001,430.0021,294,052.0015,061,864.007,716,721.0025,838,872.0026,898,364.0019,941,128.0020,263,119.00
 单季度归属母公司股东的净利润(元) 22,895,905.0017,001,430.0021,294,052.0015,061,864.007,716,721.0025,838,872.0026,898,364.0019,941,128.0020,263,119.00
 单季度经营活动产生的现金流量(元) 28,776,793.00-24,437,085.0028,209,930.00-9,400,578.0018,585,769.0019,245,373.0035,686,124.008,855,763.009,396,461.00
 单季度投资活动产生的现金流量(元) -409,037,270.00524,644,803.00-240,363,315.00-60,338,686.00-331,515,114.00-11,157,247.00174,937,790.00-133,124,301.00-230,961,741.00
 单季度筹资活动产生的现金流量(元) -32,351,570.00-17,215.00-28,124,295.00-26,871.00-99,558.00-772,687.00378,239,140.00-1,625,989.00-190,392.00
 单季度现金及现金等价物净增加(元) -412,360,821.00499,970,454.00-240,300,939.00-67,679,718.00-313,354,292.006,475,156.00590,022,983.00-122,899,287.00-222,102,491.00

前瞻产业研究院